Overall, pre-holiday market performance was high, individual stocks performed well, the profit effect of the market dropped sharply from the previous trading day, and the market's money-loss effect declined slightly from the previous trading day.
After talking about the general market data, let's focus on China Unicom's situation.
By the close of December 29, China Unicom (600050) closed at 4.38 yuan, up 0.23%. There was a slight increase before the holiday. Many fans sent me a private message backstage saying, “I'm excited. Should I increase my positions or stop making a profit after the holiday?” No rush, let me tell you right now whether China Unicom is worth investing in.
After talking about the general market data, let's focus on China Unicom's situation.
By the close of December 29, China Unicom (600050) closed at 4.38 yuan, up 0.23%. There was a slight increase before the holiday. Many fans sent me a private message backstage saying, “I'm excited. Should I increase my positions or stop making a profit after the holiday?” No rush, let me tell you right now whether China Unicom is worth investing in.
Translated
1
Specifically, Dr. Ziyad Al-Aly, a member of the research team, said that patients who were infected with COVID-19 twice or more times had a higher risk of developing lung, heart, blood, kidney, diabetes, bone, muscle, mental, and neurological diseases than others.
Also, there is little correlation between their occurrence and vaccination status.
“Even if they have been infected with COVID-19 and have completed vaccination and have double immunity, they are still prone to adverse consequences after being infected with COVID-19 again.” This is what this doctor said to Reuters
Also, there is little correlation between their occurrence and vaccination status.
“Even if they have been infected with COVID-19 and have completed vaccination and have double immunity, they are still prone to adverse consequences after being infected with COVID-19 again.” This is what this doctor said to Reuters
Translated